V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20124316 | 20087441 | 1.76 | 51.4 | Palliative (P) | null | 2019-02-13 | Rituximab | 2 | N | CAPECITABINE + STREPTOZOCIN | 100874540 |
| 20124341 | 20087442 | 1.53 | 51.2 | 03 | 2019-01-22 | 2019-01-22 | EOF | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100215886 |
| 20124365 | 20087443 | 1.79 | 107 | 03 | 2017-01-31 | 2017-02-05 | MPV (cycle 1-4) | 01 | N | NEO-AEGIS TRIAL | 101785590 |
| 20124419 | 20087444 | 1.45 | 83.05 | 03 | null | 2017-01-30 | EEF or EOF | N | null | VDC | 100264417 |
| 20124470 | 20087446 | 1.66 | 62.9 | 03 | 2017-01-10 | 2017-01-21 | Hepatoblastoma HR Cisplatin | 01 | N | GEMCITABINE + PACLITAXEL | 100368605 |
| 20124526 | 20087448 | 1.8 | 67.4 | 03 | 2018-12-07 | 2018-12-15 | MIC | 02 | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100138254 |
| 20124606 | 20087449 | 1.68 | null | Palliative (P) | 2018-11-27 | 2018-12-02 | Docetaxel | Y | null | GEMCITABINE + PACLITAXEL | 100220154 |
| 20124670 | 20087450 | 1.84 | 54 | Palliative (P) | 2016-11-13 | 2016-11-16 | Capecitabine + Streptozocin | 02 | N | CAPITAL TRIAL | 100804200 |
| 20124726 | 20087451 | 1.55 | 58.7 | 03 | 2018-11-05 | 2018-11-16 | ACELARATE Trial | N | N | IRINOTECAN | 101690378 |
| 20124748 | 20087452 | 1.73 | 82.6 | Palliative (P) | 2019-06-23 | 2019-07-11 | ARISTOTLE TRIAL | 02 | N | ACELARATE TRIAL | 101084228 |
| 20124897 | 20087453 | 1.64 | 62.2 | 03 | 2018-09-03 | 2018-09-04 | PEMBROLIZUMAB | 02 | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100410301 |
| 20124931 | 20087454 | 1.59 | 84.5 | 03 | 2017-02-16 | 2017-02-25 | EVEROLIMUS | 02 | N | CARBOPLATIN + FLUOROURACIL | 101162702 |
| 20125007 | 20087455 | 1.93 | 108 | Adjuvant (A) | null | 2018-03-25 | BALLAD Trial | 02 | N | BACILLUS CALMETTE-GUERIN | 101054220 |
| 20125023 | 20087456 | 1.7 | 62 | Curative (C) | 2019-10-17 | 2019-10-21 | VEDex | 02 | N | IBRUTINIB | 100569758 |
| 20125058 | 20087457 | 1.82 | 100.3 | Palliative (P) | 2016-11-06 | 2016-11-11 | NEO-AEGIS TRIAL | N | N | ESPAC TRIAL | 101523786 |
| 20125096 | 20087458 | 1.8 | 98 | Palliative (P) | null | 2014-07-19 | BENDAMUSTINE + RITUXIMAB | N | N | EPIRUBICIN + OXALIPLATIN + RALTITREXED | 101249771 |
| 20125195 | 20087460 | 1.76 | 59.8 | 03 | 2019-09-08 | 2019-09-08 | Cyclophosphamide oral | 02 | N | CISPLATIN + FU + TRASTUZUMAB | 100966435 |
| 20125231 | 20087462 | 1.75 | 77.9 | 03 | 2018-09-17 | 2018-09-17 | NIVOLUMAB | 01 | N | FOXTROT TRIAL | 100036978 |
| 20125242 | 20087463 | 1.7 | 64.1 | Palliative (P) | 2009-08-04 | 2019-03-27 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 01 | N | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 101546176 |
| 20125330 | 20087464 | 1.55 | 68 | Palliative (P) | 2019-09-11 | 2019-09-15 | Cisplatin + Radiotherapy | 02 | Y | TEMOZOLOMIDE | 100639935 |
| 20125380 | 20087465 | 1.7 | 86.1 | 03 | 2019-09-07 | 2019-09-22 | HEP SIOPEL 3, PLADO | N | null | BACILLUS CALMETTE-GUERIN | 100379224 |
| 20125394 | 20087466 | 1.62 | 93.3 | 03 | 2018-04-19 | 2018-04-19 | EEF or EOF | 02 | N | GEMCITABINE + PACLITAXEL | 101165653 |
| 20125466 | 20087468 | 1.61 | 78.2 | Palliative (P) | null | 2017-12-13 | Cisplatin + Vinorelbine (PO) | null | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101059715 |
| 20125483 | 20087469 | 1.76 | 92.8 | Palliative (P) | 2022-04-04 | 2022-04-12 | Paclitaxel albumin (Abraxane) 21day | 02 | N | TOPOTECAN | 101536165 |
| 20125547 | 20087470 | 1.6 | 72.2 | 03 | null | 2016-06-22 | NAB PACLITAXEL | 2 | N | EVEROLIMUS | 100696043 |
| 20125581 | 20087471 | null | null | 03 | 2017-09-06 | 2017-09-11 | CAPECITABINE + CETUXIMAB + IRINOTECAN | 02 | Y | ECARBOX | 101179710 |
| 20125601 | 20087472 | 1.76 | 61 | null | 2019-07-31 | 2019-08-27 | TEMOZOLOMIDE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101471204 |
| 20125653 | 20087473 | 1.68 | 83 | Neo-adjuvant (N) | 2018-05-22 | 2018-05-26 | PHITT Trial | 02 | N | MITOMYCIN | 100562791 |
| 20125757 | 20087475 | 1.74 | 61 | Palliative (P) | 2019-12-17 | 2019-12-22 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | CETUXIMAB + ENCORAFENIB | 100863383 |
| 20125802 | 20087476 | 1.79 | 61.5 | Palliative (P) | 2018-08-25 | 2018-09-16 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | ECARBOX | 100714583 |
| 20125855 | 20087478 | 1.69 | 63.4 | 03 | 2018-08-08 | 2018-08-29 | EEF or EOF | 02 | N | LETROZOLE + PALBOCICLIB | 100650315 |
| 20125910 | 20087479 | 1.62 | 99.6 | 03 | 2019-03-11 | 2019-04-04 | FOXTROT TRIAL | 02 | N | GO2 TRIAL | 101516936 |
| 20125941 | 20087480 | 1.65 | 76.6 | Palliative (P) | 2019-12-21 | 2019-12-23 | ARISTOTLE TRIAL | 02 | N | PLATO TRIAL | 101114560 |
| 20125986 | 20087481 | 1.77 | 47.7 | Adjuvant (A) | 2018-10-04 | 2018-10-31 | CISPLATIN + FLUOROURACIL + RT | N | N | EP | 100261119 |
| 20126014 | 20087482 | 1.82 | 55.8 | 03 | 2017-05-02 | 2017-05-03 | ARISTOTLE TRIAL | 02 | N | ECARBOX | 101616001 |
| 20126124 | 20087483 | 1.67 | 69.4 | Palliative (P) | 2017-02-25 | 2017-03-11 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | FLUOROURACIL + STREPTOZOCIN | 100320021 |
| 20126178 | 20087485 | 1.6 | 62.6 | Palliative (P) | 2019-06-07 | 2019-06-25 | PHITT B or C Cisplatin | 02 | N | SCOPE2 TRIAL | 101160470 |
| 20126182 | 20087486 | 1.59 | 56 | 03 | 2020-07-14 | 2020-07-24 | Bevacizumab + Oxaliplatin +MdG | 02 | N | CISPLATIN + RT | 101707757 |
| 20126223 | 20087487 | 1.62 | 101.9 | null | 2018-02-21 | 2018-02-21 | MIC | 02 | N | IRINOTECAN | 100471671 |
| 20126282 | 20087488 | null | 78 | Palliative (P) | 2019-03-23 | 2019-03-23 | FOXTROT TRIAL | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100561003 |
| 20126304 | 20087489 | 1.55 | 66.2 | Palliative (P) | 2017-12-31 | 2018-01-07 | Gemcitabine + Paclitaxel | 01 | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100436843 |
| 20126335 | 20087490 | 1.84 | 59.3 | Palliative (P) | 2019-07-24 | 2019-07-24 | Irinotecan 14day | 02 | N | IRINOTECAN | 101034990 |
| 20126385 | 20087491 | 0 | 0 | 03 | 2016-11-24 | 2016-12-07 | Paclitaxel 80mg/m2 day 1 8 15 | 01 | N | OXALIPLATIN | 101069118 |
| 20126429 | 20087492 | 1.53 | 74.4 | 03 | 2020-09-03 | 2020-09-05 | Irinotecan | 02 | N | EVEROLIMUS | 100168636 |
| 20126606 | 20087493 | 1.6 | 77 | null | null | 2020-01-28 | CARBO + FLUOROURACIL | 02 | N | CLADRIBINE | 101249483 |
| 20126861 | 20087494 | 1.78 | 66.8 | 03 | 2017-02-16 | 2017-03-02 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | VISMODEGIB | 100880474 |
| 20126980 | 20087496 | 1.66 | 66.7 | Palliative (P) | 2019-11-12 | 2019-12-03 | MCX | 02 | N | BORTEZOMIB + MELPHALAN | 101379299 |
| 20127030 | 20087497 | 1.6 | 61.8 | Palliative (P) | null | 2017-10-16 | THALIDOMIDE | 02 | N | NIVOLUMAB | 100414289 |
| 20127112 | 20087498 | 1.5 | 94.9 | 03 | 2022-01-24 | 2022-01-31 | FOXTROT TRIAL | null | N | CISPLATIN + FLUOROURACIL + RT | 101414123 |
| 20127240 | 20087499 | 1.84 | 71 | Palliative (P) | 2019-09-14 | 2019-09-21 | RIALTO TRIAL | 02 | N | CISPLATIN + IFOSFAMIDE + MITOMYCIN | 101503468 |